A Study of Language Interpretation Solutions for People With Breast Cancer
RSMI HEALS (Health Equity Advances Through Language Solutions) (AI)
- Breast Cancer
- Breast Cancer Stage II
- Breast Cancer Stage III
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrolment target
- 700
- Started
- 2 December 2024
- Main results due
- 2 December 2029
- Study sites
- 8
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: Phase I Patients * Age \>=18 years (per EMR) * Preferred language for healthcare is Spanish or Mandarin (per self-report) * Limited English Proficient; cannot speak English "very well" (per self-report) * Diagnosis of breast cancer or gastrointestinal (per EMR) * Will be visiting MSK oncology teams for the first or second appointment (per EMR) * Agrees to be audio-recorded (per self-report) Phase 1 Providers * Breast or gastrointestinal cancer provider who sees patients (e.g., breast or gastrointestinal oncologists, advanced practice providers, and/or nurses) * Does not speak Spanish and/or Mandarin; providers who speak one language and not the other may participate (e.g., speaks Spanish but not Mandarin) (per self-report) * Agrees to be audio-record (per self-report) Phase 2 (clinic staff only; patient participants will be drawn from Phase 1) * Is a staff member who works/worked in one of the study clinic sites during the period of Phase 1 RCT study activities * Agrees to be audio-recorded (per self-report) Exclusion Criteria: Phase 1 Patients * Has significant psychiatric disturbance (i.e., acute psychiatric symptoms) sufficient to preclude completion of the assessments, interviews, or informed consent (per EMR, patient's care team, or study team) * Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patients, care team, or study team) Phase I Providers * None Phase 2 (clinic staff only; Phase 1 patient participants follow above criteria) * None
What this study is about
In the sponsor’s own words, from the registry.
The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.
Study sites(8)
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey, United States
Recruiting
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, New Jersey, United States
Recruiting
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey, United States
Recruiting
Memorial Sloan Kettering Suffolk- Commack (Consent Only)
Commack, New York, United States
Recruiting
Memorial Sloan Kettering Westchester (Consent Only)
Harrison, New York, United States
Recruiting
Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities)
New York, New York, United States
Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Recruiting
Memorial Sloan Kettering Nassau (All Protocol Activities)
Rockville Centre, New York, United States
Recruiting
Showing 8 of 8 sites. 8 of the 8 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06721065. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me